{
    "id": "0678",
    "question": "A researcher is interested in identifying the most effective treatment for uncomplicated urinary tract infections (UTI) in women between the ages of 18 and 50. Of 200 consecutive women who present to the emergency room for such a UTI, 50 are randomized to each of the following: nitrofurantoin 100 mg every 12 hours for 5 days, nitrofurantoin 100 mg every 12 hours for 7 days, cefpodoxime 100 mg every 12 hours for 5 days, and cefpodoxime 100 mg every 12 hours for 7 days. The measured outcomes include progression to pyelonephritis, positive urine culture on day 7 after initiation of treatment, and likelihood of re-presenting to the emergency room for another UTI within 90 days. Which of the following best describes this type of study?",
    "options": {
        "A": "Parallel study",
        "B": "Factorial design study",
        "C": "Between patient study",
        "D": "Cluster randomized trial"
    },
    "answer": "B",
    "predict": "To determine the type of study, let's break down the scenario: 1. The researcher is interested in identifying the most effective treatment for uncomplicated UTI in women between the ages of 18 and 50. 2. 200 consecutive women are selected for the study. 3. The participants are randomized to one of four different treatment groups (nitrofurantoin 100 mg every 12 hours for 5 days, nitrofurantoin 100 mg every 12 hours for 7 days, cefpodoxime 100 mg every 12 hours for 5 days, and cefpodoxime 100 mg every 12 hours for 7 days). 4. The outcomes measured include progression to pyelonephritis, positive urine culture on day 7 after initiation of treatment, and likelihood of re-presenting to the emergency room for another UTI within 90 days. Given these details, this is a randomized controlled trial (RCT) with multiple treatment arms. However, since the participants are not assigned to groups based on a specific factor (e.g., age, comorbidities), but rather are randomly assigned to one of the four treatment groups, this is a type of parallel RCT. Here is the output in the requested format: {\"step_by_step_thinking\": \"The study is a randomized controlled trial (RCT) with multiple treatment arms, where 200 consecutive women are randomly assigned to one of four different treatment groups. This is a parallel RCT, as the participants are randomly assigned to groups without any grouping based on a specific factor.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Gynecology_Novak_2937",
            "title": "Gynecology_Novak",
            "content": "Acute Pyelonephritis The clinical spectrum of acute, uncomplicated pyelonephritis in young women ranges from gram-negative septicemia to a cystitislike illness with mild \ufb02ank pain. E. coli accounts for more than 80% of these cases (58). Microscopy of unspun urine reveals pyuria and gram-negative bacteria. A urine culture should be obtained in all women with suspected pyelonephritis; blood cultures should be performed in those who are hospitalized because results are positive in 15% to 20% of cases. In the absence of nausea and vomiting and severe illness, outpatient oral therapy can be given safely. Patients who have nausea and vomiting, are moderately to severely ill, or are pregnant should be hospitalized. Outpatient treatment regimens include trimethoprim/ sulfamethoxazole (160/800 mg every 12 hours for 14 days) or a quinolone (e.g., levo\ufb02oxacin, 750 mg daily for 7 days). Inpatient treatment regimens include the use of parenteral levo\ufb02oxacin (750 mg daily), ceftriaxone (1\u20132 g"
        },
        {
            "id": "First_Aid_Step2_496",
            "title": "First_Aid_Step2",
            "content": "FIGURE 2.8-12. Chancroid. Multiple, painful ulcers. (Reproduced, with permission, from Wolff K et al. Fitzpatrick\u2019s Color Atlas & Synopsis of Clinical Dermatology, 5th ed. New York: McGraw-Hill, 2005: Fig. 27-31.) Pregnant patients: Treat asymptomatic bacteruria or symptomatic UTI with nitrofurantoin or cephalosporin \u00d7 3\u20137 days. Avoid f uoroquinolones. Confrm clearance with a repeat culture post-treatment. Patients with urosepsis should be hospitalized and initially treated with IV antibiotics. Consider broader coverage to include resistant GNRs or enterococcus. Prophylactic antibiotics may be given to women with uncomplicated recurrent UTIs. Check for prostatitis in men. Nearly 85% of community-acquired cases of pyelonephritis result from the same pathogens that cause cystitis. Cystitis and pyelonephritis have similar risk factors. \u25a0Signs and symptoms are similar to those of cystitis but show evidence of upper urinary tract disease."
        },
        {
            "id": "Obstentrics_Williams_7284",
            "title": "Obstentrics_Williams",
            "content": "Nitrofurantoin, 100 mg four times daily for 21 days Nitrofurantoin, 100 mg at bedtime for pregnancy remainder Lower urinary infection during pregnancy may develop without antecedent covert bacteriuria (Harris, 1981). Cystitis produces dysuria, urgency, and frequency, but with few associated systemic indings. Pyuria and bacteriuria are usually found. Microscopic hematuria is common, and occasionally there is gross hematuria from hemorrhagic cystitis. Although cystitis is usually uncomplicated, the upper urinary tract may become involved by ascending infection. Almost 40 percent of pregnant women with acute pyelonephritis have preceding symptoms of lower tract infection (Gilstrap, 1981a). Women with cystitis respond readily to any of several regimens. Most of the 3-day regimens listed in Table 53-1 are usually 90-percent efective (Fihn, 2003). Single-dose therapy is less efective, and if it is used, concomitant pyelonephritis must be confidently excluded."
        },
        {
            "id": "Obstentrics_Williams_7281",
            "title": "Obstentrics_Williams",
            "content": "Bacteriuria responds to empirical treatment with any of several antimicrobial regimens listed in Table Although selection can be based on in vitro susceptibilities, in our extensive experience, empirical oral treatment for 10 days with nitrofurantoin macrocrystals, 100 mg at bedtime, is usually efective. Satisfactory results are also achieved with a 7-day oral course of nitrofurantoin, 100 mg given twice daily (Lumbiganon, 2009). Single-dose antimicrobial therapy is less successful (Widmer, 2015). The important caveat is that, regardless of regimen given, the recurrence rate is approximatey 30 percent. This may indicate covert upper tract infection and the need for longer therapy. hus, after initial therapy, periodic surveillance is necessary to prevent recurrent urinary infections (Schneeberger, 2015)."
        },
        {
            "id": "First_Aid_Step2_493",
            "title": "First_Aid_Step2",
            "content": "Microscopic analysis: Pyuria (> 5 WBCs/hpf) and bacteriuria (1 organism/hpf = 106 organisms/mL) are suggestive. Urine culture: The gold standard is > 105 CFU/mL. Uncomplicated UTI: Treat on an outpatient basis with PO TMP-SMX or a f uoroquinolone \u00d7 3 days, or nitrofurantoin \u00d7 7 days. Note that resistance to TMP-SMX and fuoroquinolones has been increasing. Complicated UTI (urinary obstruction, men, renal transplant, catheters, instrumentation): Administer the same antibiotics as above, but for 7\u201314 days. Common UTI bugs\u2014 SEEKS PP Serratia E. coli Enterobacter Klebsiella pneumoniae S. saprophyticus Pseudomonas Proteus mirabilis T AB LE 2.8-8. Sexually Transmitted Genital Lesions"
        },
        {
            "id": "Obstentrics_Williams_7282",
            "title": "Obstentrics_Williams",
            "content": "For recurrent bacteriuria, we have had success with nitrofurantoin, 100 mg orally at bedtime for 21 days (Lucas, 1994). For women with persistent or frequent bacteriuria recurrences, suppressive therapy for the remainder of pregnancy can be given. We routinely use nitrofurantoin, 100 mg orally at bedtime. This drug may rarely cause an acute pulmonary reaction that dissipates on its withdrawal (Boggess, 1996). TABLE 53-1. Oral Antimicrobial Agents Used for Treatment of Pregnant Women with Asymptomatic Bacteriuria Amoxicillin,n3 9 Ampicillin,n2 9 Cephalosporin, 2 9 Nitrofurantoin, 200 mg Trimethoprim-sulfamethoxazole, 320/1600 mg Amoxicillin, 500 mg three times daily Ampicillin, 250 mg four times daily Cephalosporin, 250 mg four times daily Ciprofloxacin, 250 mg twice daily Levofloxacin, 250 or 500 mg daily Nitrofurantoin, 50 to 100 mg four times daily or 100 mg twice daily Trimethoprim-sulfamethoxazole, 160/800 mg twice daily"
        },
        {
            "id": "Pediatrics_Nelson_2428",
            "title": "Pediatrics_Nelson",
            "content": "is uncertainty about diagnosis of UTI in a younger child or Neonates with UTI are treated for 10 to 14 days with par-infant, urine can be collected by the most convenient method enteral antibiotics because of the higher rate of bacteremia. for urinalysis and if suggestive of infection, collect urine by Older children with UTI are treated for 7 to 14 days. Initial catheterization prior to starting antibiotics. treatment with parenteral antibiotics is determined by clinical status. Parenteral antibiotics should be continued until there is clinical improvement (typically 24 to 48 hours). Specificantibiotic therapy should be guided by the local antimicrobial susceptibility patterns and the results of the patient\u2019surine cultures because of increasing problems related to antimicrobial resistance. Commonly used parenteral antibiotics include ceftriaxone or gentamicin. Oral regimens include acephalosporin, amoxicillin plus clavulanic acid, or trimethoprim sulfamethoxazole. Infants and"
        },
        {
            "id": "Gynecology_Novak_3602",
            "title": "Gynecology_Novak",
            "content": "The treatment of urinary tract infection includes hydration and antibiotic therapy. Commonly prescribed and effective antibiotics include penicillin, sulfonamides, cephalosporins, \ufb02uoroquinolones, and nitrofurantoin. The choice of antibiotic should be based on knowledge of the susceptibility of organisms cultured at a particular institution. In some institutions, for example, more than 40% of E. coli strains are resistant to ampicillin. For uncomplicated urinary tract infections, an antibiotic that has good activity against E. coli should be given in the interim while awaiting results of the urine culture and sensitivity data."
        },
        {
            "id": "Gynecology_Novak_2938",
            "title": "Gynecology_Novak",
            "content": "mg every 12 hours for 14 days) or a quinolone (e.g., levo\ufb02oxacin, 750 mg daily for 7 days). Inpatient treatment regimens include the use of parenteral levo\ufb02oxacin (750 mg daily), ceftriaxone (1\u20132 g daily), ampicillin (1 g every 6 hours), and gentamicin (especially if Enterococcus species are suspected) or aztreonam (1 g every 8\u201312 hours). Symptoms should resolve after 48 to 72 hours. If fever and \ufb02ank pain persist after 72 hours of therapy, ultrasound or computed tomography should be considered to rule out a perinephric or intrarenal abscess or ureteral obstruction. A follow-up culture should be obtained 2 weeks after the completion of therapy (60)."
        },
        {
            "id": "Gynecology_Novak_2387",
            "title": "Gynecology_Novak",
            "content": "Expectant medical treatment consists of oral hydration or intravenous \ufb02uids (if the patient is unable to tolerate oral intake), antibiotics for UTI, and pain control. Surgical management, such as lithotripsy or open surgery, is an option for renal and urethral lithiasis. Nonpregnant women (and pregnant women who are afebrile with a normal WBC count) with pyelonephritis and all women with cystitis can be treated on an outpatient basis. Nonpregnant women with pyelonephritis can be treated with a 14-day course of a \ufb02uoroquinolone or trimethoprim/ sulfamethoxazole (some recommend one intravenous dose of a third-generation cephalosporin before discharging patients with oral antibiotics) (see Chapter 18) (32). Caution should be used with trimethoprim/sulfamethoxazole given rising resistance patterns. It is important to follow up urine culture sensitivities and treat accordingly. If there is no improvement, raising concerns for patient compliance, inability to tolerate oral medications and"
        },
        {
            "id": "Obstentrics_Williams_7297",
            "title": "Obstentrics_Williams",
            "content": "Recurrent urinary tract infection-either covert or symptomatic-develops in 30 to 40 percent of women following completion of pyelonephritis treatment (Cunningham, 1973). Unless other measures are taken to ensure urine sterility, nitrofurantoin, 100 mg orally at bedtime given for the remainder of the pregnancy, reduces bacteriuria recurrence (Van Dorsten, 1987)."
        },
        {
            "id": "InternalMed_Harrison_10680",
            "title": "InternalMed_Harrison",
            "content": "organism, but other aerobic gram-negative rods, such as Pseudomonas aeruginosa and Klebsiella, Proteus, Citrobacter, Acinetobacter, and Morganella species, also are frequently isolated. Gram-positive bacteria (e.g., enterococci and Staphylococcus aureus) and yeasts are also important pathogens in complicated UTI. Data on etiology and resistance are generally obtained from laboratory surveys and should be understood in the context that organism identification is performed only in cases in which urine is sent for culture\u2014i.e., typically, when complicated UTI or pyelonephritis is suspected. The available data demonstrate a worldwide increase in the resistance of E. coli to antibiotics commonly used to treat UTI. North American and European surveys from women with acute cystitis have documented resistance rates of >20% to trimethoprim-sulfamethoxazole (TMP-SMX) and to ciprofloxacin in some regions. In community-acquired infections, the increased prevalence of uropathogens producing"
        },
        {
            "id": "InternalMed_Harrison_12444",
            "title": "InternalMed_Harrison",
            "content": "Extraintestinal Infectious Syndromes \u2022 Urinary tract infection The urinary tract is the site most frequently infected by ExPEC. An exceedingly common infection among ambulatory patients, UTI accounts for 1% of ambulatory care visits in the United States and is second only to lower respiratory tract infection among infections responsible for hospitalization. UTIs are best considered by clinical syndrome (e.g., uncomplicated cystitis, pyelonephritis, and catheter-associated UTIs) and within the context of specific hosts (e.g., premenopausal women, compromised hosts; Chap. 162). E. coli is the single most common pathogen for all UTI syndrome/host group combinations. Each year in the United States, E. coli causes 80\u201390% of an estimated 6\u20138 million episodes of uncomplicated cystitis in premenopausal women. Furthermore, 20% of women with an initial cystitis episode develop frequent recurrences."
        },
        {
            "id": "InternalMed_Harrison_10679",
            "title": "InternalMed_Harrison",
            "content": "The uropathogens causing UTI vary by clinical syndrome but are usually enteric gram-negative rods that have migrated to the urinary tract. The susceptibility patterns of these organisms vary by clinical syndrome and by geography. In acute uncomplicated cystitis in the United States, the etiologic agents are highly predictable: E. coli accounts for 75\u201390% of isolates; Staphylococcus saprophyticus for 5\u201315% (with particularly frequent isolation from younger women); and Klebsiella, Proteus, Enterococcus, and Citrobacter species, along with other organisms, for 5\u201310%. Similar etiologic agents are found in Europe and Brazil. The spectrum of agents causing uncomplicated pyelonephritis is similar, with E. coli predominating. In complicated UTI (e.g., CAUTI), E. coli remains the predominant organism, but other aerobic gram-negative rods, such as Pseudomonas aeruginosa and Klebsiella, Proteus, Citrobacter, Acinetobacter, and Morganella species, also are frequently isolated. Gram-positive"
        },
        {
            "id": "InternalMed_Harrison_12445",
            "title": "InternalMed_Harrison",
            "content": "Uncomplicated cystitis, the most common acute UTI syndrome, is characterized by dysuria, urinary frequency, and suprapubic pain. Fever and/or back pain suggests progression to pyelonephritis. Even with appropriate treatment of pyelonephritis, fever may take 5\u20137 days to resolve completely. Persistently elevated or increasing fever and neutrophil counts should prompt evaluation for intrarenal or perinephric abscess and/or obstruction. Renal parenchymal damage and loss of renal function during pyelonephritis occur primarily with urinary obstruction, which can be preexisting or, rarely, occurs de novo in diabetic patients who develop renal papillary necrosis as a result of kidney infection. Pregnant women are at unusually high risk for developing pyelonephritis, which can adversely affect the outcome of pregnancy. As a result, prenatal screening for and treatment of asymptomatic bacteriuria are standard. Prostatic infection is a potential complication of UTI in men. The diagnosis and"
        },
        {
            "id": "InternalMed_Harrison_10719",
            "title": "InternalMed_Harrison",
            "content": "Traditionally, TMP-SMX has been recommended as first-line treatment for acute cystitis, and it remains appropriate to consider the use of this drug in regions with resistance rates not exceeding 20%. TMP-SMX resistance has clinical significance: in TMP-SMX-treated patients with resistant isolates, the time to symptom resolution is longer and rates of both clinical and microbiologic failure are higher. Individual host factors associated with an elevated risk of UTI caused by a strain of E. coli resistant to TMP-SMX include recent use of TMPSMX or another antimicrobial agent and recent travel to an area with high rates of TMP-SMX resistance. The optimal setting for empirical use of TMP-SMX is uncomplicated UTI in a female patient who has an established relationship with the practitioner and who can thus seek further care if her symptoms do not respond promptly. aMicrobial response as measured by reduction of bacterial counts in the urine."
        },
        {
            "id": "InternalMed_Harrison_10724",
            "title": "InternalMed_Harrison",
            "content": "Since patients with pyelonephritis have tissue-invasive disease, the treatment regimen chosen should have a very high likelihood of eradicating the causative organism and should reach therapeutic blood levels quickly. High rates of TMP-SMX-resistant E. coli in patients with pyelonephritis have made fluoroquinolones the first-line therapy for acute uncomplicated pyelonephritis. Whether the fluoroquinolones are given orally or parenterally depends on the patient\u2019s tolerance for oral intake. A randomized clinical trial demonstrated that a 7-day course of therapy with oral ciprofloxacin (500 mg twice daily, with or without an initial IV 400-mg dose) was highly effective for the initial management of pyelonephritis in the outpatient setting. Oral TMP-SMX (one double-strength tablet twice daily for 14 days) also is effective for treatment of acute uncomplicated pyelonephritis if the uropathogen is known to be susceptible. If the pathogen\u2019s susceptibility is not known and TMPSMX is used, an"
        },
        {
            "id": "InternalMed_Harrison_10725",
            "title": "InternalMed_Harrison",
            "content": "for 14 days) also is effective for treatment of acute uncomplicated pyelonephritis if the uropathogen is known to be susceptible. If the pathogen\u2019s susceptibility is not known and TMPSMX is used, an initial IV 1-g dose of ceftriaxone is recommended. Oral \u03b2-lactam agents are less effective than the fluoroquinolones and should be used with caution and close follow-up. Options for parenteral therapy for uncomplicated pyelonephritis include fluoroquinolones, an extended-spectrum cephalosporin with or without an aminoglycoside, or a carbapenem. Combinations of a \u03b2-lactam and a \u03b2-lactamase inhibitor (e.g., ampicillin-sulbactam, ticarcillinclavulanate, piperacillin-tazobactam) or imipenem-cilastatin can be used in patients with more complicated histories, previous episodes of pyelonephritis, or recent urinary tract manipulations; in general, the treatment of such patients should be guided by urine culture results. Once the patient has responded clinically, oral therapy should be substituted"
        },
        {
            "id": "InternalMed_Harrison_10674",
            "title": "InternalMed_Harrison",
            "content": "Urinary Tract Infections, Pyelonephritis, and Prostatitis 862 Many factors predisposing women to cystitis also increase the risk of pyelonephritis. Factors independently associated with pyelonephritis in young healthy women include frequent sexual intercourse, a new sexual partner, a UTI in the previous 12 months, a maternal history of UTI, diabetes, and incontinence. The common risk factors for cystitis and pyelonephritis are not surprising given that pyelonephritis typically arises through the ascent of bacteria from the bladder to the upper urinary tract. However, pyelonephritis can occur without clear antecedent cystitis. About 20\u201330% of women who have had one episode of UTI will have recurrent episodes. Early recurrence (within 2 weeks) is usually regarded as relapse rather than reinfection and may indicate the need to evaluate the patient for a sequestered focus. Intracellular pods of infecting organisms within the bladder epithelium have been demonstrated in animal models of"
        },
        {
            "id": "InternalMed_Harrison_10716",
            "title": "InternalMed_Harrison",
            "content": "In 1999, TMP-SMX was recommended as the first-line agent for treatment of uncomplicated UTI in the published guidelines of the Infectious Diseases Society of America. Antibiotic resistance among uropathogens causing uncomplicated cystitis has since increased, appreciation of the importance of collateral damage (as defined below) has increased, and newer agents have been studied. Unfortunately, there is no longer a single best agent for acute uncomplicated cystitis."
        },
        {
            "id": "Obstentrics_Williams_7283",
            "title": "Obstentrics_Williams",
            "content": "Levofloxacin, 250 or 500 mg daily Nitrofurantoin, 50 to 100 mg four times daily or 100 mg twice daily Trimethoprim-sulfamethoxazole, 160/800 mg twice daily Nitrofurantoin, 100 mg four times daily for 10 days Nitrofurantoin, 100 mg twice daily for 5 to 7 days Nitrofurantoin, 100 mg at bedtime for 10 days Nitrofurantoin, 100 mg four times daily for 21 days Nitrofurantoin, 100 mg at bedtime for pregnancy remainder"
        },
        {
            "id": "Surgery_Schwartz_2887",
            "title": "Surgery_Schwartz",
            "content": "catheters and followers may be used, but these can potentially cause bladder injury. If endoscopic attempts fail, the patient may require a percutaneously placed suprapubic catheter to obtain decompression of the bladder. Follow-up investigations of these patients are recommended so definitive care of the ure-thral abnormalities can be pursued.The most frequent nosocomial infection is urinary tract infection (UTI). These infections are classified into compli-cated and uncomplicated forms. The uncomplicated type is a UTI that can be treated with outpatient antibiotic therapy. The complicated UTI usually involves a hospitalized patient with an indwelling catheter whose UTI is diagnosed as part of a fever workup. The interpretation of urine culture results of less than 100,000 CFU/mL is controversial. Before treating such a patient, one should change the catheter and then repeat the cul-ture to see if the catheter was simply colonized with organisms. Cultures with more than 100,000"
        },
        {
            "id": "InternalMed_Harrison_10721",
            "title": "InternalMed_Harrison",
            "content": "Resistance to nitrofurantoin remains low despite >60 years of use. Since this drug affects bacterial metabolism in multiple pathways, several mutational steps are required for the development of resistance. Nitrofurantoin remains highly active against E. coli and most non\u2013E. coli isolates. Proteus, Pseudomonas, Serratia, Enterobacter, and yeasts are all intrinsically resistant to this drug. Although nitrofurantoin has traditionally been prescribed as a 7-day regimen, similar microbiologic and clinical efficacies are noted with a 5-day course of nitrofurantoin or a 3-day course of TMP-SMX for treatment of women with acute cystitis; 3-day courses of nitrofurantoin are not recommended for acute cystitis. Nitrofurantoin does not reach significant levels in tissue and cannot be used to treat pyelonephritis."
        },
        {
            "id": "InternalMed_Harrison_10718",
            "title": "InternalMed_Harrison",
            "content": "Several effective therapeutic regimens are available for acute uncomplicated cystitis in women (Table 162-1). Well- studied first-line agents include TMP-SMX and nitrofurantoin. Second-line agents include fluoroquinolone and \u03b2-lactam compounds. Single-dose fosfomycin treatment for acute cystitis is widely used in Europe but has produced mixed results in randomized trials. There is increasing experience with the use of fosfomycin against UTIs (including complicated infections) caused by multidrugresistant E. coli. Pivmecillinam is not currently available in the United States or Canada but is a popular agent in some European countries. The pros and cons of other therapies are discussed briefly below."
        },
        {
            "id": "Gynecology_Novak_2933",
            "title": "Gynecology_Novak",
            "content": "Treatment High concentrations of trimethoprim and \ufb02uoroquinolone in vaginal secretions can eradicate E. coli while minimally altering normal anaerobic and microaerophilic vaginal \ufb02ora. An increasing linear trend in the prevalence of resistance of E. coli (>10%) to the \ufb02uoroquinolones (e.g., cipro\ufb02oxacin) was noted. Despite a similar increase in E. coli resistance (9%\u201318%) to trimethoprim/sulfamethoxazole, therapeutic efficacy remains stable. In contrast, no such increase in resistance was noted with nitrofurantoin. Nitrofurantoin (macrocrystals, 100 mg orally twice daily for 5 days) or trimethoprim/sulfamethoxazole 160/800 mg orally twice daily for 3 days) are the optimal choices for empirical therapy for uncomplicated cystitis (59)."
        },
        {
            "id": "Gynecology_Novak_807",
            "title": "Gynecology_Novak",
            "content": "improved in 48 to 72 hours. If these give only a minimal or no response after 7 days, consider broader spectrum antibiotics. If beta-lactam resistance is likely, amoxicillin/clavulanic acid (875 mg twice daily) or azithromycin (5-day course once a day) may be used. Other second-line drugs include cefuroxime (250 mg twice daily), cipro\ufb02oxacin (500 mg twice daily), clarithromycin (500 mg twice daily), levo\ufb02oxacin (500 mg once a day), and loracarbef (400 mg twice daily). The usual treatment course is 10 to 14 days, and patients should be informed that relapses might occur if the full course of treatment is not completed."
        },
        {
            "id": "InternalMed_Harrison_10704",
            "title": "InternalMed_Harrison",
            "content": "non-urinary cause Consider acute prostatitis Urinalysis and culture Consider urology evaluation Consider uncomplicated cystitis or STD Dipstick, urinalysis, and culture STD evaluation, pelvic exam Consider uncomplicated cystitis No urine culture needed Consider telephone management Consider complicated UTI, CAUTI, or pyelonephritis Urine culture Blood cultures Exchange or remove catheter if present Consider complicated UTI Urinalysis and culture Address any modifiable anatomic or functional abnormalities Consider uncomplicated pyelonephritis Urine culture Consider outpatient management Consider ASB Screening and treatment warranted Consider pyelonephritis Urine culture Blood cultures Consider ASB No additional workup or treatment needed Consider CA-ASB No additional workup or treatment needed Remove unnecessary catheters Consider recurrent cystitis Urine culture to establish diagnosis Consider prophylaxis or patient-initiated management Consider chronic bacterial prostatitis"
        },
        {
            "id": "InternalMed_Harrison_10697",
            "title": "InternalMed_Harrison",
            "content": "DIAGNOSTIC TOOLS History The diagnosis of any of the UTI syndromes or ASB begins with a detailed history (Fig. 162-4). The history given by the patient has a high predictive value in uncomplicated cystitis. A meta-analysis evaluating the probability of acute UTI on the basis of history and physical findings concluded that, in women presenting with at least one symptom of UTI (dysuria, frequency, hematuria, or back pain) and without complicating factors, the probability of acute cystitis or pyelonephritis is 50%. The even higher rates of accuracy of self-diagnosis among women with recurrent UTI probably account for the success of patient-initiated treatment of recurrent cystitis. If vaginal discharge and complicating factors are absent and risk factors for UTI are present, then the probability of UTI is close to 90%, and no laboratory evaluation is needed. Similarly, a combination of dysuria and urinary frequency in the absence of vaginal discharge increases the probability of UTI to"
        },
        {
            "id": "Surgery_Schwartz_1922",
            "title": "Surgery_Schwartz",
            "content": "or aztreonam is a reasonable alternative. Fluoroquinolones should not be used for prophylaxis in cesarean section.7Age >70 y, acute cholecystitis, nonfunctioning gallbladder, obstructive jaundice, or common duct stones.8Cefotetan, cefoxitin, and ampicillin/sulbactam are reasonable alternatives.9In addition to mechanical bowel preparation, 1 g of neomycin plus 1 g of erythromycin at 1 p.m., 2 p.m., and 11 p.m. or 2 g of neomycin plus 2 g of metronidazole at 7 p.m. and 11 p.m. the day before an 8 a.m. operation.10Due to increasing resistance of E. coli to fluoroquinolones and ampicillin/sulbactam, local sensitivity profiles should be reviewed prior to use.11For a ruptured viscous, therapy is often continued for about 5 d.12Urine culture positive or unavailable, preoperative catheter, transrectal prostate biopsy, or placement of prosthetic material.13Shock wave lithotripsy, ureteroscopy.14Including percutaneous renal surgery, procedures with entry into the urinary tract, and those"
        },
        {
            "id": "Obstentrics_Williams_7293",
            "title": "Obstentrics_Williams",
            "content": "Antimicrobial therapy usually is empirical, and ampicillin plus gentamicin; cefazolin or ceftriaxone; or an extended-spectrum antibiotic are all 95-percent efective in randomized trials (Sanchez-Ramos, 1995; Wing, 1998,a2000). Fewer than half of E coli strains are sensitive to ampicillin in vitro, but cephalosporins and gentamicin generally have excellent activity. Serum creatinine levels are monitored if nephrotoxic drugs are given. Initial treatment at Parkland Hospital is ampicillin plus gentamicin. Some recommend suitable substitutes if bacterial studies show in vitro resistance. With any of the regimens discussed, response is usually prompt, and 95 percent of women are afebrile by 72 hours (Hill, 2005; Sheield, 2005). ter discharge, most recommend oral therapy for a total of7 to 14 days (Hooton, 2012)."
        },
        {
            "id": "InternalMed_Harrison_10668",
            "title": "InternalMed_Harrison",
            "content": "urinary Tract Infections, 162 Pyelonephritis, and Prostatitis Kalpana Gupta, Barbara W. Trautner Urinary tract infection (UTI) is a common and painful human illness that, fortunately, is rapidly responsive to modern antibiotic therapy. In the preantibiotic era, UTI caused significant morbidity. Hippocrates, writing about a disease that appears to have been acute cystitis, said that the illness could last for a year before either resolving or worsening to involve the kidneys. When chemotherapeutic agents used to treat UTI were introduced in the early twentieth century, they were relatively ineffective, and persistence of infection after 3 weeks of therapy was common. Nitrofurantoin, which became available in the 1950s, was the first tolerable and effective agent for the treatment of UTI."
        },
        {
            "id": "InternalMed_Harrison_10710",
            "title": "InternalMed_Harrison",
            "content": "The approach to diagnosis is influenced by which of the clinical UTI syndromes is suspected (Fig. 162-4). Uncomplicated Cystitis in Women Uncomplicated cystitis in women can be treated on the basis of history alone. However, if the symptoms are not specific or if a reliable history cannot be obtained, then a urine dipstick test should be performed. A positive nitrite or leukocyte esterase result in a woman with one symptom of UTI increases the probability of UTI from 50% to ~80%, and empirical treatment can be considered without further testing. In this setting, a negative dipstick result does not rule out UTI, and a urine culture, close clinical follow-up, and possibly a pelvic examination are recommended. These recommendations are made with the caveat that no factors associated with complicated UTI, such as pregnancy, are known to be present."
        }
    ],
    "scores": [
        0.03729731354796493,
        0.034415577336322056,
        0.034161844371004585,
        0.03240517261492443,
        0.03111208825034674,
        0.029618223530871603,
        0.02769574995866044,
        0.02597172715851681,
        0.025855063944178584,
        0.024181532678452383,
        0.02352741696575433,
        0.023349729635443923,
        0.02329815647189108,
        0.023268690354883534,
        0.02303007070448931,
        0.02253402987740314,
        0.02230140222760885,
        0.02212146936255595,
        0.022083958285813905,
        0.021650741579664488,
        0.021625248436842638,
        0.020930401863715784,
        0.020287718644028292,
        0.019327731092436976,
        0.019222861191773112,
        0.019022081774146302,
        0.019017094017094015,
        0.018042071197411004,
        0.017592241027720504,
        0.0174984783931832,
        0.017174311926605505,
        0.017095265926358856
    ]
}